HIV/AIDS BOARD REVIEW Harold Henderson, MD Diagnosis Natural History Clinical Manifestations Drug Therapy, Toxicity, Interactions Opportunistic Infections-diagnosis,
Adherence Preparing to start ARVs Dr. Kevin M Harvey MBBS, MPH (UWI), Dip. ID (Lon.) Treatment care and support 2006.
Accelerating Anti-Retroviral Treatment as a catalytic action for Ending AIDS Pride Chigwedere, MD, PhD Senior Advisor to the African Union AWA CONSULTATIVE.
Multi State Models in R
Epidemic and Pandemic Use of Antivirals Introduction 15 September 2008 Frederick G. Hayden, M.D. University of Virginia Health System Charlottesville,
S.Collins: HIV i-Base HIV Positive Conference Taiwan - September 2005 [email protected] Life experience: self empowerment.
HIV Cellular Pathogenesis III Benhur Lee, M.D.. Adult v. infant (IgG v. IgA) CTL response (MHC tetramers) p24 antigenimia Ab response Viral load.
Housing as a Structural Intervention for Transgender People living with HIV/AIDS Megan Stanton, MSW* Sambuddha Choudhuri* Samira Ali, MSW* Lynn Walker,
ХРОНИЧЕСКИЙ ГЕПАТИТ В: СОВРЕМЕННЫЕ СТРАТЕГИИ ЛЕЧЕНИЯ
Outcome of 2009 Quality Management Site Visits. OAMC – Outpatient/Ambulatory Medical Care, MCM – Medical Case Management, SA – Substance Abuse Readiness,
Housing as a Structural Intervention for Transgender People living with HIV/AIDS
Shifting Surveillance Paradigms CDC Perspective Irene Hall, PhD, FACE HIV Incidence and Case Surveillance Branch 2012 CSTE Annual Conference HIV Surveillance.
